What Self-Sampling for Women’s Health Testing Means for Labs
The enhancement of women’s health is a focal point for many companies, and is projected to reach $75.1 billion by 2025.
Read MorePosted by Chris Wolski | Jun 28, 2023 | Womens Health |
The enhancement of women’s health is a focal point for many companies, and is projected to reach $75.1 billion by 2025.
Read MorePosted by Chris Wolski | Jun 27, 2023 | Diabetes & Metabolic Diseases |
New research from NIH found that blood glucose levels obtained at childhood examinations predicted future diabetes-related complications.
Read MorePosted by Melanie Hamilton-Basich | Jun 26, 2023 | Cervical (HPV), Point-of-Care |
A low-cost, point-of-care DNA test for HPV infections that was invented at Rice University delivers results in 45 minutes and requires just two pieces of equipment.
Read MorePosted by Melanie Hamilton-Basich | Jun 23, 2023 | Unknown Origin & Other Cancer Types |
Precipio Inc. and an academic healthcare institution will jointly develop a panel for Glioblastoma based on Precipio’s HemeScreen technology.
Read MorePosted by Melanie Hamilton-Basich | Jun 20, 2023 | Dementias & Alzheimer’s, Rapid Assays |
Aptamer Group plc and Neuro-Bio have developed Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer’s disease.
Read More